Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Autolus Therapeutics (AUTL) Shares Outstanding (Diluted Average): 2020-2025

Historic Shares Outstanding (Diluted Average) for Autolus Therapeutics (AUTL) over the last 4 years, with Sep 2025 value amounting to $266.1 million.

  • Autolus Therapeutics' Shares Outstanding (Diluted Average) rose 0.02% to $266.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $266.1 million, marking a year-over-year increase of 0.02%. This contributed to the annual value of $255.2 million for FY2024, which is 46.69% up from last year.
  • Per Autolus Therapeutics' latest filing, its Shares Outstanding (Diluted Average) stood at $266.1 million for Q3 2025, which was up 0.00% from $266.1 million recorded in Q2 2025.
  • In the past 5 years, Autolus Therapeutics' Shares Outstanding (Diluted Average) registered a high of $266.1 million during Q3 2025, and its lowest value of $86.1 million during Q1 2021.
  • In the last 3 years, Autolus Therapeutics' Shares Outstanding (Diluted Average) had a median value of $266.1 million in 2024 and averaged $247.7 million.
  • Data for Autolus Therapeutics' Shares Outstanding (Diluted Average) shows a peak YoY surged of 92.91% (in 2021) over the last 5 years.
  • Over the past 5 years, Autolus Therapeutics' Shares Outstanding (Diluted Average) (Quarterly) stood at $97.2 million in 2021, then climbed by 7.00% to $107.5 million in 2022, then reached $173.9 million in 2023, then surged by 46.69% to $255.2 million in 2024, then climbed by 0.02% to $266.1 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $266.1 million in Q3 2025, compared to $266.1 million in Q2 2025 and $266.1 million in Q1 2025.